Interpretation of Genotype and Pharmacokinetics for Resistance to Fosamprenavir-Ritonavir-Based Regimens in Antiretroviral-Experienced Patients

In this study, named the Zephir study (Telzir-pharmacokinetics), 121 antiretroviral-experienced human immunodeficiency virus (HIV) patients failing on highly active antiretroviral therapy (HAART) were included in a prospective cohort and received a fosamprenavir-ritonavir (700 mg/100 mg twice a day)...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Pellegrin, Isabelle, Breilh, Dominique, Coureau, Gaelle, Boucher, Sébastien, Neau, Didier, Merel, Patrick, Lacoste, Denis, Fleury, Hervé, Saux, Marie-Claude, Pellegrin, Jean-Luc, Lazaro, Estibaliz, Dabis, François, Thiébaut, Rodolphe
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2007
Assuntos:
Antiviral Agents
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1855517/
https://ncbi.nlm.nih.gov/pubmed/17296739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00481-06
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares